Duhay Francis sold 11 enVVeno Medical Corp shares at $11.21 per share. The director owned 2,351 shares after the transaction, which represented about 0.5% of his prior holding, giving investors the reported size of the insider trade relative to his position.
Key Highlights
- Duhay Francis owned 2,351 enVVeno Medical Corp shares after the transaction.
- The filing identifies the transaction with SEC code S.
- Duhay Francis sold 11 enVVeno Medical Corp shares at $11.21 per share on 11 September 2026.
EnVVeno Medical Corp (NASDAQ: NVNO) director Duhay Francis sold 11 shares at $11.21 per share on 11 September 2026. Following the transaction, Francis owned 2,351 shares of enVVeno Medical Corp.
Transaction Leaves 2,351 Shares
The transaction date was 11 September 2026. The reported share count applies after the sale.
Transaction Equalled About 0.5% of Prior Holding
The transaction represented about 0.5% of Francis’s prior shareholding. The 2,351-share figure records the position afterward.
FAQs
Q: What did Duhay Francis sell in enVVeno Medical Corp?
A: Duhay Francis sold 11 enVVeno Medical Corp shares at $11.21 per share on 11 September 2026. The filing identifies Francis as a director and reports the sale in a Form 4.
Q: What was the impact of the NVNO insider sale on Francis’s holdings?
A: Following the transaction, Duhay Francis owned 2,351 enVVeno Medical Corp shares. The filing states that the sale represented about 0.5% of his prior shareholding.
Q: Was the enVVeno Medical transaction an open-market sale?
A: The filing identifies the transaction with SEC code S. The source document does not further characterize that code as an open-market sale.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.